NOVAREMED AG
Novaremed AG is a clinical-stage Swiss biopharmaceutical company.
NOVAREMED AG
Industry:
Biotechnology
Founded:
2017-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.novaremed.com
Total Employee:
1+
Status:
Active
Total Funding:
52.62 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible WordPress Font Awesome Euro Contact Form 7 WPBakery WordPress 5.2
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
Eli Kaplan Founder and CEO @ Novaremed AG
Founder and CEO
2008-12-01
Isaac Kobrin Executive Chairman of the Board of Directors @ Novaremed AG
Executive Chairman of the Board of Directors
2017-01-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-09-07 | Metys Pharmaceuticals | Metys Pharmaceuticals acquired by Novaremed AG | N/A |
Investors List
The Global Emerging Markets Group
The Global Emerging Markets Group investment in Private Equity Round - Novaremed AG
Official Site Inspections
http://www.novaremed.com Semrush global rank: 5.29 M Semrush visits lastest month: 1.56 K
- Host name: ec2-18-102-82-159.eu-south-1.compute.amazonaws.com
- IP address: 18.102.82.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Novaremed AG"
Home | Novaremed
Jan 31, 2023 Novaremed’s pipeline to address peripheral neuropathy and neuropathic pain focuses on three non-opioid development projects with entirely different modes of action: …See details»
About - Novaremed
Prior to joining Novaremed, he was founder, President and Chief Executive Officer at Arvelle Therapeutics, where he led the organization through the approval of its lead product by EMA …See details»
Novaremed AG - Crunchbase Company Profile
Organization. Novaremed AG . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ...See details»
Novaremed Company Profile | Management and Employees List
Novaremed's clinical development portfolio aims to satisfy high medical patient needs and societal demands by alleviating the burden of pain associated with diabetes and cancer for patients …See details»
Novaremed - Headquarter Location, Corporate Office Address and …
Novaremed is Drug Discovery in Switzerland that focus on healthcare organizations business. Founded in 2008. They cover business area such as developer, pharmaceutical drug, small …See details»
Novaremed 2025 Company Profile: Valuation, Funding …
Novaremed General Information Description. Developer of pharmaceutical drugs using small bio-molecules designed for the treatment of neuropathic pain. The company develops an orally active non-opioid small molecule with a novel …See details»
Novaremed AG – Swiss Biotech
Novaremed AG, a privately held clinical-stage biopharmaceutical company, is innovating chronic pain management through the development of effective and safe treatment options as an …See details»
Novaremed AG - Funding, Financials, Valuation & Investors
Novaremed AG is funded by The Global Emerging Markets Group. Novaremed AG has acquired Metys Pharmaceuticals on Sep 7, 2021. Unlock for free . ... How much funding has this …See details»
Novaremed AG Overview | SignalHire Company Profile
Novaremed AG is a private company that has been in the industry for 15 years. The company currently specializes in the Biotechnology area. ... Organization Website: novaremed.com : …See details»
Novaremed Company Profile - Office Locations, Competitors
Novaremed has 5 employees at their 1 location and $13.27 m in total funding,. See insights on Novaremed including office locations, competitors, revenue, financials, executives, …See details»
Novaremed - teaserclub.com
Novaremed AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland. Founded in 2008, it focuses on developing NRD.E1, an orally active New Chemical Entity …See details»
News January 28, 2021 | Novaremed
Novaremed Ltd, a wholly owned subsidiary of Novaremed AG was founded in 2008 in Israel and Novaremed AG was founded in 2017 in Switzerland. Novaremed aims to become a leader in …See details»
Novaremed AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Novaremed AG of Basel, BASEL-STADT. Get the latest business insights from Dun & Bradstreet.See details»
Novaremed AG - Contacts, Employees, Board Members
Novaremed AG is a clinical-stage Swiss biopharmaceutical company. AI Content may contain mistakes and is not legal, financial or investment advice.See details»
Novaremed - Overview, News & Similar companies | ZoomInfo.com
Who is Novaremed. Novaremed AG, a privately held clinical-stage biopharmaceutical company, is innovating chronic pain management through the development of effective and safe treatment …See details»
News June 23, 2022 | Novaremed
Basel, Switzerland, June 23, 2022 – Novaremed AG, a privately held clinical-stage biopharmaceutical company focused on innovative non-opioid treatment options for chronic …See details»
Novaremed raises CHF2.5 million and prepares Phase2b clinical …
Sep 21, 2020 Novaremed also announced that its PCT patent application covering a targeted therapy to treat pain and inflammation was published on July 30, 2020. Dr. Eli Kaplan, …See details»
News September 7, 2021 | Novaremed
Novaremed AG, a privately held clinical-stage biopharmaceutical company, is innovating chronic pain management through the development of effective and safe treatment options as an …See details»
New Novartis Phase III data demonstrate meaningful efficacy and …
5 days ago Patient organization funding Payments to healthcare professionals Public policy A living wage A safe workplace Animal research Environmental, social and governance. Learn …See details»
News December 21, 2021 | Novaremed
Basel, Switzerland, December 21, 2021 – Novaremed AG, a privately held clinical-stage biopharmaceutical company, announces a study with the National Institutes of Health (NIH) …See details»